10 20 30 40 50 60 70 80 2R9M - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 13-SEP-07 2R9M
TITLE CATHEPSIN S COMPLEXED WITH COMPOUND 15
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN S; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.27; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HYDROLASE, CATHEPSIN, PROTEASE, GLYCOPROTEIN, LYSOSOME, KEYWDS 2 POLYMORPHISM, THIOL PROTEASE, ZYMOGEN
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.D.WARD,M.J.EMMANUEL,D.S.THOMSON,W.LIU,Y.BEKKALI,L.L.FRYE, AUTHOR 2 M.GIRARDOT,T.MORWICK,E.R.R.YOUNG,R.ZINDELL,M.HRAPCHAK, AUTHOR 3 M.DETURI,A.WHITE,K.M.CRANE,D.M.WHITE,Y.WANG,M.-H.HAO, AUTHOR 4 C.A.GRYGON,M.E.LABADIA,J.WILDESON,D.FREEMAN,R.NELSON, AUTHOR 5 A.CAPOLINO,J.D.PETERSON,E.L.RAYMOND,M.L.BROWN,D.M.SPERO
REVDAT 2 24-FEB-09 2R9M 1 VERSN REVDAT 1 18-DEC-07 2R9M 0
JRNL AUTH Y.D.WARD,M.J.EMMANUEL,D.S.THOMSON,W.LIU,Y.BEKKALI, JRNL AUTH 2 L.L.FRYE,M.GIRARDOT,T.MORWICK,E.R.R.YOUNG, JRNL AUTH 3 R.ZINDELL,M.HRAPCHAK,M.DETURI,A.WHITE,K.M.CRANE, JRNL AUTH 4 D.M.WHITE,Y.WANG,M.-H.HAO,C.A.GRYGON,M.E.LABADIA, JRNL AUTH 5 J.WILDESON,D.FREEMAN,R.NELSON,A.CAPOLINO, JRNL AUTH 6 J.D.PETERSON,E.L.RAYMOND,M.L.BROWN,D.M.SPERO JRNL TITL DESIGN AND SYNTHESIS OF REVERSIBLE INHIBITORS OF JRNL TITL 2 CATHEPSIN S: ALPHA,ALPHA-DISUBSTITUTION AT THE P1 JRNL TITL 3 RESIDUE PROVIDES POTENT INHIBITORS IN CELLULAR JRNL TITL 4 ASSAYS AND IN VIVO MODELS OF ANTIGEN PRESENTATION JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 98.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 38819 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1972 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 449 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.85 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2R9M COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-SEP-07. REMARK 100 THE RCSB ID CODE IS RCSB044597.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC FOCUSSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38822 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 14.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.16100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1MS6 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM NAOAC, 18-35% PEG MME (500- REMARK 280 8000), 2 M (NH4)2SO4 WITH OR WITHOUT 15% GLYCEROL, PH 4.6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.16550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.58275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 112.74825 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 75.16550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 112.74825 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 37.58275 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 440 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 372 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 413 LIES ON A SPECIAL POSITION.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 218 REMARK 465 HIS A 219 REMARK 465 HIS A 220 REMARK 465 HIS A 221 REMARK 465 HIS A 222 REMARK 465 HIS B 218 REMARK 465 HIS B 219 REMARK 465 HIS B 220 REMARK 465 HIS B 221 REMARK 465 HIS B 222
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 149 CG CD NE CZ NH1 NH2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 25 C27 Y11 B 281 1.88 REMARK 500 SG CYS A 25 C27 Y11 A 281 1.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 58 -126.49 -110.73 REMARK 500 THR B 58 -130.44 -108.26 REMARK 500 ARG B 141 31.30 -92.90 REMARK 500 ASN B 163 -1.93 -147.85 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2R9N RELATED DB: PDB REMARK 900 RELATED ID: 2R9O RELATED DB: PDB
DBREF 2R9M A 1 217 UNP P25774 CATS_HUMAN 115 331 DBREF 2R9M B 1 217 UNP P25774 CATS_HUMAN 115 331
SEQADV 2R9M HIS A 218 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS A 219 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS A 220 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS A 221 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS A 222 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS B 218 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS B 219 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS B 220 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS B 221 UNP P25774 EXPRESSION TAG SEQADV 2R9M HIS B 222 UNP P25774 EXPRESSION TAG
SEQRES 1 A 222 LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS VAL SEQRES 2 A 222 THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA CYS TRP SEQRES 3 A 222 ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU LYS SEQRES 4 A 222 LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN ASN SEQRES 5 A 222 LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS GLY SEQRES 6 A 222 CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR ILE SEQRES 7 A 222 ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR PRO SEQRES 8 A 222 TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER LYS SEQRES 9 A 222 TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU PRO SEQRES 10 A 222 TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA ASN SEQRES 11 A 222 LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS PRO SEQRES 12 A 222 SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU PRO SEQRES 13 A 222 SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL VAL SEQRES 14 A 222 GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU VAL SEQRES 15 A 222 LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY TYR SEQRES 16 A 222 ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY ILE SEQRES 17 A 222 ALA SER PHE PRO SER TYR PRO GLU ILE HIS HIS HIS HIS SEQRES 18 A 222 HIS SEQRES 1 B 222 LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS VAL SEQRES 2 B 222 THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA CYS TRP SEQRES 3 B 222 ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU LYS SEQRES 4 B 222 LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN ASN SEQRES 5 B 222 LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS GLY SEQRES 6 B 222 CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR ILE SEQRES 7 B 222 ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR PRO SEQRES 8 B 222 TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER LYS SEQRES 9 B 222 TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU PRO SEQRES 10 B 222 TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA ASN SEQRES 11 B 222 LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS PRO SEQRES 12 B 222 SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU PRO SEQRES 13 B 222 SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL VAL SEQRES 14 B 222 GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU VAL SEQRES 15 B 222 LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY TYR SEQRES 16 B 222 ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY ILE SEQRES 17 B 222 ALA SER PHE PRO SER TYR PRO GLU ILE HIS HIS HIS HIS SEQRES 18 B 222 HIS
HET Y11 A 281 29 HET Y11 B 281 29
HETNAM Y11 N-[(1S)-2-[(4-CYANO-1-METHYLPIPERIDIN-4-YL)AMINO]-1- HETNAM 2 Y11 (CYCLOHEXYLMETHYL)-2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE
FORMUL 3 Y11 2(C21 H35 N5 O3) FORMUL 5 HOH *449(H2 O)
HELIX 1 1 ARG A 8 GLY A 11 5 4 HELIX 2 2 ALA A 24 GLY A 43 1 20 HELIX 3 3 SER A 49 SER A 57 1 9 HELIX 4 4 THR A 58 GLY A 62 5 5 HELIX 5 5 LYS A 64 GLY A 68 5 5 HELIX 6 6 PHE A 70 LYS A 82 1 13 HELIX 7 7 ASP A 102 LYS A 104 5 3 HELIX 8 8 ARG A 120 LYS A 131 1 12 HELIX 9 9 HIS A 142 LEU A 147 1 6 HELIX 10 10 ASN A 204 ILE A 208 5 5 HELIX 11 11 ARG B 8 GLY B 11 5 4 HELIX 12 12 ALA B 24 GLY B 43 1 20 HELIX 13 13 SER B 49 SER B 57 1 9 HELIX 14 14 THR B 58 GLY B 62 5 5 HELIX 15 15 LYS B 64 GLY B 68 5 5 HELIX 16 16 PHE B 70 LYS B 82 1 13 HELIX 17 17 ASP B 102 LYS B 104 5 3 HELIX 18 18 ARG B 120 LYS B 131 1 12 HELIX 19 19 HIS B 142 TYR B 148 1 7 HELIX 20 20 ASN B 204 ILE B 208 5 5
SHEET 1 A 3 VAL A 5 ASP A 6 0 SHEET 2 A 3 HIS A 164 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 A 3 VAL A 134 VAL A 138 -1 N VAL A 134 O VAL A 168 SHEET 1 B 4 VAL A 5 ASP A 6 0 SHEET 2 B 4 HIS A 164 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 B 4 LYS A 177 LYS A 183 -1 O LYS A 183 N LEU A 167 SHEET 4 B 4 TYR A 195 ALA A 199 -1 O MET A 198 N TRP A 180 SHEET 1 C 2 ILE A 84 ASP A 85 0 SHEET 2 C 2 ARG A 106 ALA A 108 -1 O ALA A 107 N ILE A 84 SHEET 1 D 2 LYS A 112 GLU A 115 0 SHEET 2 D 2 SER A 213 GLU A 216 -1 O GLU A 216 N LYS A 112 SHEET 1 E 3 VAL B 5 ASP B 6 0 SHEET 2 E 3 HIS B 164 LEU B 174 -1 O TYR B 171 N VAL B 5 SHEET 3 E 3 VAL B 134 VAL B 138 -1 N VAL B 136 O VAL B 166 SHEET 1 F 5 VAL B 5 ASP B 6 0 SHEET 2 F 5 HIS B 164 LEU B 174 -1 O TYR B 171 N VAL B 5 SHEET 3 F 5 LYS B 177 LYS B 183 -1 O LYS B 183 N LEU B 167 SHEET 4 F 5 TYR B 195 ALA B 199 -1 O MET B 198 N TRP B 180 SHEET 5 F 5 VAL B 152 TYR B 153 1 N TYR B 153 O ARG B 197 SHEET 1 G 2 ILE B 84 ASP B 85 0 SHEET 2 G 2 ARG B 106 ALA B 108 -1 O ALA B 107 N ILE B 84 SHEET 1 H 2 LYS B 112 GLU B 115 0 SHEET 2 H 2 SER B 213 GLU B 216 -1 O TYR B 214 N THR B 114
SSBOND 1 CYS A 22 CYS A 66 1555 1555 2.04 SSBOND 2 CYS A 56 CYS A 99 1555 1555 2.04 SSBOND 3 CYS A 158 CYS A 206 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 66 1555 1555 2.04 SSBOND 5 CYS B 56 CYS B 99 1555 1555 2.03 SSBOND 6 CYS B 158 CYS B 206 1555 1555 2.04
CRYST1 85.273 85.273 150.331 90.00 90.00 90.00 P 41 2 2 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011727 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011727 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006652 0.00000